This guide provides actionable steps for medical device manufacturers to implement and maintain continuous cybersecurity monitoring throughout the device lifecycle, focusing on SBOM analysis and vulnerability management. It covers premarket preparation through postmarket surveillance and audit readiness.
Every CVE deserves a recorded outcome — even "not affected" — to satisfy FDA postmarket expectations.
Ensure complete mapping of your software supply chain by ingesting SPDX, CycloneDX, or custom SBOM formats. Generate an SBOM if one does not exist, and perform normalization and version resolution to clean raw SBOM data. Crucially, track firmware and embedded components frequently missed by generic scanners.
Prioritize CVEs based on your device's specific architecture, factoring in network exposure, exploitability, and clinical risk, not just CVSS scores. Link cyber risk directly to potential patient harm as per ISO 14971, and track vendor advisories and End-of-Life (EOL) statuses.
Generate compliance artifacts and postmarket surveillance documentation aligned with FDA postmarket cybersecurity guidance (Section 524B), IEC 62304 / IEC 81001-5-1, and EU MDR/IVDR requirements. Maintain audit-ready vulnerability timelines, including triage decisions, remediation actions, and SBOM change history for exportable evidence packs.
Utilize continuous scanning of SBOM components against the NVD and vendor advisories for real-time CVE detection from premarket to postmarket. Set up prioritized alerts for new vulnerabilities and manage patches proactively to maintain continuous compliance.
Seek guidance from senior medical device cybersecurity experts for vulnerability reviews and to tune triage rules to your specific risk profile. This specialized expertise is crucial for navigating MedTech-specific challenges.
Aim for rapid onboarding to continuous monitoring systems (e.g., in 1-2 weeks) to avoid delays associated with typical enterprise platforms. Ensure that vulnerability timelines, triage decisions, remediation actions, and SBOM change history are integrated into your Quality Management System (QMS) for ongoing audit readiness.
Authoritative guidance and standards underpinning this topic. Always confirm the latest revision with the publisher.
Quick answers to the questions teams most often ask about this topic.
Continuous monitoring is the ongoing process of watching newly disclosed vulnerabilities (CVEs) against your SBOM, prioritizing by exploitability and patient safety impact, and feeding the results into your postmarket vulnerability management process.
Most medical device vulnerabilities originate in third-party or open-source components, not in your own code. Without continuous SBOM monitoring you will miss high-severity issues like Log4Shell or Ripple20 until customers, researchers, or regulators surface them.
Medical devices cannot usually be patched on a normal IT cadence, run on long-lived embedded platforms, and have safety implications for every change. Monitoring must integrate with risk assessment and the change-control process, not just generate CVE lists.
Jump to all guides for the lifecycle phase that fits where you are.